Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

RBC Life Sciences Denies Acquisition Report

RBC Life Sciences
Posted on: 29 Sep 17

IRVING, Texas, Sept. 28, 2017 /PRNewswire/ -- RBC Life Sciences, Inc. (the "Company") announced today that, contrary to a recent public announcement, the Company is not presently engaged in any discussions with the Vast Bright Group of Companies or their affiliates (collectively, "Vast Bright") regarding the acquisition of a portion of the Company's shares or any other business relationship.  Further, the Company announced that it does not foresee any circumstances under which it would entertain any such discussions with Vast Bright in the future.

About RBC Life Sciences
Through wholly owned subsidiaries, RBC Life Sciences develops, manufactures and markets high-quality nutritional supplements under the RBC Life brand to a growing population of consumers seeking healthy lifestyle and an opportunity to increase their long-term family income. Through its wholly owned subsidiary, MPM Medical, the Company also develops and markets to health care professionals in the United States proprietary prescription and nonprescription products for advanced wound care and pain management. For more information, visit the company's website at

The statements above, other than statements of historical fact, which express a belief, expectation or intention may be forward-looking statements.  Actual events will be dependent upon a number of factors and risks including, but not limited to, changes in plans by the Company's management,  changes in the regulatory process or laws affecting the Company's business, changes in market trends, and a number of other factors and risks.  Forward-looking statements are made based on management's current expectations and beliefs concerning future events. Although we believe that the expectations reflected in these forward-looking statements are reasonable, we can give no assurance that such expectations will prove to have been correct.  Further, we specifically disclaim any duty to update any of the information set forth in this press release, including any forward-looking statement.


For Further Information:


Steven E. Brown, President, CEO


Tel:  972-893-4000

Editor's Details

Mike Wood

Last updated on: 29/09/2017

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.